Kim McLeod, MPH, is a Senior Director and leads Prospective Research within the Real World Evidence (RWE) team at Xcenda. In this role, she leads a team that supports RWE engagements that include the design and execution of retrospective chart reviews and prospective clinical studies. Ms. McLeod has extensive experience building clinical trial organizations, creating electronic data capture systems, and developing processes to support global clinical development programs.

With more than 20 years of global pharmaceutical and medical device development experience, Ms. McLeod’s diverse background includes roles within start-up biotech companies, federal institutions, contract research organizations (CROs), and large pharmaceutical companies. Her work in global pharmaceutical drug development has resulted in several drug approvals, and her expertise is all encompassing including creation and execution of full clinical development programs from phase 1 through phase 4. In addition to her development experience, she has created several clinical and data management organizations from inception.

Ms. McLeod’s experience is diverse and expands across multiple therapeutic areas, including cardiovascular, dermatology, endocrinology, gastroenterology, hematology, neurology, nephrology, obstetrics and gynecology oncology, ophthalmology, psychiatry, respiratory, and rheumatology. Ms. McLeod received her BS in Biology and Master in Public Health degrees from the University of South Florida.